Your browser doesn't support javascript.
loading
MYO-MRI diagnostic protocols in genetic myopathies.
Warman Chardon, Jodi; Díaz-Manera, Jordi; Tasca, Giorgio; Bönnemann, Carsten G; Gómez-Andrés, David; Heerschap, Arend; Mercuri, Eugenio; Muntoni, Francesco; Pichiecchio, Anna; Ricci, Enzo; Walter, Maggie C; Hanna, Michael; Jungbluth, Heinz; Morrow, Jasper M; Fernández-Torrón, Roberto; Udd, Bjarne; Vissing, John; Yousry, Tarek; Quijano-Roy, Susana; Straub, Volker; Carlier, Robert Y.
Afiliação
  • Warman Chardon J; Neuromuscular Centre. The Ottawa Hospital, Canada; Neurogenetics Children's Hospital of Eastern Ontario, Canada.
  • Díaz-Manera J; Neuromuscular Disorders Unit, Neurology department, Hospital Universitari de la Santa Creu i Sant Pau, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain.
  • Tasca G; Neurology, Fondazione Policlinico A. Gemelli IRCSS, Italy.
  • Bönnemann CG; National Institute of Neurological Disorders and Stroke, National Institute of Health, United States.
  • Gómez-Andrés D; Pediatric Neurology, Hospital Universitari Vall d'Hebron, Spain.
  • Heerschap A; Department of Radiology, Radboud University Nijmegen Medical Center, the Netherlands.
  • Mercuri E; Pediatric Neurology, Catholic University, Policlinico Gemelli, Italy; Centro Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
  • Muntoni F; Paediatric Neurology, Dubowitz Neuromuscular Centre, UCL Institute of Child Health and Great Ormond Street Hospital for Children, UK.
  • Pichiecchio A; University of Pavia and Department of Neuroradiology IRCCS Mondino Foundation Pavia, Italy.
  • Ricci E; Institute of Neurology, Catholic University, Italy.
  • Walter MC; Friedrich-Baur Institut, Dept. of Neurology, Ludwig-Maximilians University Munich, Germany.
  • Hanna M; Department of Neuromuscular Diseases, University College London, Queen Square Institute of Neurology, UK.
  • Jungbluth H; Paediatric Neurology, King's College London, UK.
  • Morrow JM; Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, UK.
  • Fernández-Torrón R; Biodonostia Health Research Institute, Neuromuscular Area, Hospital Donostia, Neurology Department, 20014 Donostia - San Sebastian, Spain.
  • Udd B; Neuromuscular Centre, University of Tampere, Finland.
  • Vissing J; Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
  • Yousry T; Neuroradiology, University College London, UK.
  • Quijano-Roy S; APHP, Neuromuscular Unit, Department of Pediatric Neurology and Intensive cares, CHU Raymond Poincare (UVSQ), Garches, France.
  • Straub V; John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK.
  • Carlier RY; Robert-Yves Carlier, Service de Radiologie et Imagerie Médicale Hôpital Raymond Poincaré, Hôpitaux de Paris (AP-HP), Garches, France; Centre de référence des maladies neuro-musculaires Paris-Nord-ESt, Filenemus, France. Electronic address: robert.carlier@aphp.fr.
Neuromuscul Disord ; 29(11): 827-841, 2019 11.
Article em En | MEDLINE | ID: mdl-31727541
Whole-body magnetic resonance imaging has emerged as a useful imaging tool in diagnosing and characterizing the progression of myopathies and muscular dystrophies. Whole-body MRI indications and diagnostic efficacy are becoming better defined with the increasing number of cases, publications and discussions within multidisciplinary working groups. Advanced Whole-body MRI protocols are rapid, lower cost, and well-tolerated by patients. Accurate interpretation of muscle Whole-body MRI requires a detailed knowledge of muscle anatomy and differential pattern of involvement in muscle diseases. With the surge in recently identified novel genetic myopathies, Whole-body MRI will become increasingly useful for phenotypic validation of genetic variants of unknown significance. In addition, Whole-body MRI will be progressively used as a biomarker for disease progression and quantify response to therapy with the emergence of novel disease modifying treatments. This review outlines Whole-body MRI indications and updates refined protocols and provides a comprehensive overview of the diagnostic utility and suggested methodology of Whole-body MRI for pediatric and adult patients with muscle diseases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Imagem Corporal Total / Doenças Musculares Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Imagem Corporal Total / Doenças Musculares Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article